PHS
WST icon

PFM Health Sciences’s West Pharmaceutical WST Stock Holding History

PFM Health Sciences’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.44M Buy
+20,733
New +$6.34M 0.64% 55
2025
Q4 		– Sell
-18,365
Closed -$4.82M – 102
2025
Q3 		$4.82M Buy
+18,365
New +$4.46M 0.37% 52
2024
Q2 		– Sell
-51,197
Closed -$20.3M – 93
2024
Q1 		$20.3M Buy
+51,197
New +$18.9M 0.95% 38

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PFM Health Sciences's WST Position: Q2 2026 in Review

PFM Health Sciences opened a new position in West Pharmaceutical (WST) in Q2 2026: 20,733 shares worth $7.44M. The stake represents 0.64% of the portfolio and ranks #55 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in WST as recently as Q3 2025.

PFM Health Sciences first reported a position in WST in Q1 2024 and has held it in 3 quarters since. The position peaked at $20.3M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • PFM Health Sciences held 20,733 shares of West Pharmaceutical worth $7.44M as of Q2 2026.
  • West Pharmaceutical was a new PFM Health Sciences position in Q2 2026.
  • West Pharmaceutical made up 0.64% of PFM Health Sciences's portfolio in Q2 2026, its #55 holding.
  • PFM Health Sciences first reported a position in West Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
  • PFM Health Sciences's West Pharmaceutical position peaked at $20.3M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.